Health-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone.
暂无分享，去创建一个
F. Saad | C. Redfern | N. Clarke | J. Jassem | B. Alekseev | A. Thiery-Vuillemin | A. Degboe | N. Sala | C. Goessl | P. Wiechno | V. Chiuri | I. Kocák | J. Burgents | C. Gresty | A. Flechon | R. Jones